At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 66 enrolled
Drug / intervention
Transdermal Lidocaine Patch +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Transdermal Lidocaine Patch for Post-Cesarean Pain Control for Women With Obesity: a Single-blind Randomized Controlled Trial
In Brief
A Phase 4 clinical trial evaluating Transdermal Lidocaine Patch and Transdermal Hydrocolloid Placebo Patch for Pain, Postoperative. Completed, enrolled 66 participants across 1 site.
Detailed Summary
This study will be a single-center, single blind, randomized controlled trial. The study will be conducted at UnityPoint-Health Meriter Hospital under investigators from the University of Wisconsin-Madison. Obstetric patients with prepregnancy obesity undergoing a Cesarean delivery at UnityPoint-Health Meriter will be eligible.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Postoperative
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20192020202120222023202420252026
First PostedJan 2019
Enrollment StartFeb 2019
Primary CompletionSep 2019
Study CompletionNov 2019
TodayJul 2026
First PostedJan 18, 2019
Enrollment StartFeb 15, 2019
Primary CompletionSep 9, 2019
Study CompletionNov 30, 2019
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 7.5 years ago
Interventions
Transdermal Lidocaine Patchdrug
Transdermal Lidocaine Patch
Transdermal Hydrocolloid Placebo Patchdrug
hydrocolloid placebo patches